- Early Bird
- Posts
- Ethereum Hits All-Time High 💰
Ethereum Hits All-Time High 💰
And, Keurig Dr Pepper eyes coffee biz.
Today is Monday, August 25, 2025.
The Early Bird Index today is 91.34
New to this newsletter? Sign up here
PRESENTED BY THE NEW MONEY
Discover the world’s most exciting stocks
Did you hear? There’s a new free app that can connect you to smarter insights on what’s happening with the markets at any moment.
The New Money makes it easier than ever to discover up-and-coming public companies, new IPOs, emerging themes, and the bets being made by some of the world’s smartest investors.
Explore top-performing companies and trends, track your portfolio, and get real-time alerts. Check out daily exclusive content on the world’s most exciting stocks and investing trends.
It’s the markets and trends that matter, made simple.
Ethereum Hits All-Time High 💰
Ethereum $ETH.X ( â–¼ 4.06% ) reached an all-time high on Sunday at around $4,900, capping off an incredible summer for the second-most popular cryptocurrency.
Price: Ethereum has increased by over 90% since the start of July. Over the past 30 days, it has jumped nearly 30%.
Recent Developments: Crypto prices surged on Friday after Federal Reserve Chair Jerome Powell suggested that there might be potential rate cuts in the coming weeks.
Early Bird’s Nest Egg Gains: Several developments have attracted traders and investors to Ethereum in recent months.
Institutional investment is at unprecedented levels, with U.S.-listed spot Ether ETFs seeing record inflows.
Regulatory reforms and new legislation supporting stablecoins and digital assets have improved Ethereum’s outlook.
Network improvement (such as the Pectra update) and rising on-chain activity from DeFi and NFTs have strengthened the fundamental case for Ethereum.
Final Thoughts: Since Ethereum’s 90% breakout on July 1, Bitcoin $BTC.X ( ▼ 2.68% ) is up only about 6%.
Notables
Notable Earnings Today: PDD Holdings (Nasdaq: PDD), Semtech (Nasdaq: SMTC), HEICO (NYSE: HEI), Napco Security Technologies (Nasdaq: NSSC).
Notable IPOs Today: N/A.
Notable Equity Crowdfunding Campaigns Ending Today: Norr Organic (StartEngine), Web3AIstore (StartEngine), Harvest Moon Coffee & Chocolates (Honeycomb).
Notable Economic Events Today: Building Permits (8:00 a.m. ET), New Home Sales (10:00 a.m. ET).
Keurig Dr Pepper Eyes Coffee Biz
As consumers diversify their beverage choices, Keurig Dr Pepper $KDP ( â–¼ 0.19% ) might be aiming to make a change with its drink empire.
Details: The Wall Street Journal reported on Sunday that Keurig Dr Pepper is nearing an $18 billion deal to acquire the coffee company JDE Peet. The report, which has not been confirmed by the companies yet, claims that the combined company plans to later separate its beverage and coffee units.
Background: Shares of Keurig Dr Pepper are up 10.63% this year. Its most recent financial results were solid but not spectacular. The company also reaffirmed its full-year financial outlook.
Final Thoughts: JDE Peet’s stock is up 82.83% in 2025.
Verint Systems Might Get Acquired
It’s been a tough year for investors of Verint Systems $VRNT ( ▲ 6.01% ) , which makes products for customer experience automation, but the company’s future might be different.
Details: Bloomberg reported on Sunday that private equity firm Thoma Bravo is planning to acquire Verint Systems for about $2 billion.
Background: The company’s financial results earlier in 2025 disappointed investors, but its most recent financial results in the summer have shown improvement.
Final Thoughts: Vertint Systems is down 23.48% this year.
Trends to Watch
First Time: ‘KPop Demon Hunters’ Becomes Netflix’s First Box Office No. 1 (TheWrap)
Big Week: Nvidia Earnings Are the Stock Market Risk Event After Fed Rally (Bloomberg)
Nightmare Over: This Is the End of China’s Once Mightiest Property Firm (New York Times)
Going Down South: Meta is sinking $10 billion into rural Louisiana to build the home of its wildest AI aspirations, setting the template for the nation’s grid buildout (Fortune)
Weight Loss Drug Competition: Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors (CNBC)
Thank you for reading!
Forward to a friend and tell them to sign up here.
Pick winning stocks: Upgrade to Early Bird Prime.
Be social: Like our Facebook page and follow us on Twitter.
Want more investing tips? Listen to the podcast.
Show Your Support: Buy Me a Coffee.
Questions or comments? Hit reply to reach out.
The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.